Kidney Today Blog

Before we break out the new calendar and say goodbye to 2025, AKF is reflecting on another big year for our work fighting kidney disease on all fronts

4 key takeaways from the American Heart Association's new High Blood Pressure Guideline

Nephrologists Dr. Anita Mehrotra and Dr. Etti Zeldis share the unique challenges veterans face, how military service can affect kidney health and the stories that inspire them in their work

AKF presents three posters at the 2025 American Society of Nephrology's annual meeting in Houston, Texas

The Transforming Kidney Health Research's roadmap to making this vision a reality

Kathy Wong, a registered dietitian nutritionist and a member of AKF Dietitian Advisory Group for Kidney Kitchen®, answers questions about protein supplements and kidney disease.

Pride Month is a time to lift up LGBTQ+ voices. It's also an opportunity to reflect on the work that's still needed to advance equity in critical spaces, including within health care.

Learn more about the connection between pneumonia and acute kidney injury

In January 2025, FDA approved an injectable form of semaglutide (GLP1-RA) to treat CKD in people with type 2 diabetes. Here are 6 important things you need to know about GLP1-RAs, CKD and the FDA approval.